Canada markets closed

Biotage AB (publ) (0GRP.L)

LSE - LSE Delayed Price. Currency in SEK
Add to watchlist
216.59+4.79 (+2.26%)
At close: 05:13PM BST
Currency in SEK

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.80
52-Week Change 3-31.75%
S&P500 52-Week Change 322.38%
52 Week High 3215.00
52 Week Low 3104.80
50-Day Moving Average 3121.61
200-Day Moving Average 3143.66

Share Statistics

Avg Vol (3 month) 313.6k
Avg Vol (10 day) 39.72k
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 865.96M
% Held by Insiders 10.45%
% Held by Institutions 180.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 31.60
Trailing Annual Dividend Yield 30.76%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 11.91%
Operating Margin (ttm)12.92%

Management Effectiveness

Return on Assets (ttm)5.78%
Return on Equity (ttm)8.46%

Income Statement

Revenue (ttm)1.98B
Revenue Per Share (ttm)25.61
Quarterly Revenue Growth (yoy)33.00%
Gross Profit (ttm)N/A
EBITDA 460M
Net Income Avi to Common (ttm)236M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)-23.30%

Balance Sheet

Total Cash (mrq)683M
Total Cash Per Share (mrq)8.54
Total Debt (mrq)257M
Total Debt/Equity (mrq)6.61%
Current Ratio (mrq)2.16
Book Value Per Share (mrq)48.61

Cash Flow Statement

Operating Cash Flow (ttm)381M
Levered Free Cash Flow (ttm)357.42M